---
title: "SER.US (SER.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SER.US/news.md"
symbol: "SER.US"
name: "SER.US"
parent: "https://longbridge.com/en/quote/SER.US.md"
datetime: "2026-05-21T23:16:50.342Z"
locales:
  - [en](https://longbridge.com/en/quote/SER.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SER.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SER.US/news.md)
---

# SER.US (SER.US) — Related News

### [Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks](https://longbridge.com/en/news/286635474.md)
*2026-05-16T06:00:57.000Z*
> Serina Therapeutics, Inc. disclosed a PIPE deal involving director Gregory H. Bailey, which may dilute existing sharehol

### [Serina Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286460398.md)
*2026-05-14T20:10:40.000Z*
### [Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | SER Stock News](https://longbridge.com/en/news/286462168.md)
*2026-05-14T12:20:29.000Z*
> Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates | SER Stock News

### [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://longbridge.com/en/news/286258576.md)
*2026-05-13T12:06:16.000Z*
> In Wednesday's pre-market session, Quantum Cyber (NASDAQ:QUCY) shares surged 55% to $0.5, while SELLAS Life Sciences Gr 

### [Fatty15 Co-Founder, Dr. Stephanie Venn-Watson, Named 2026 LA Times Life Sciences Visionary](https://longbridge.com/en/news/284394148.md)
*2026-04-28T13:01:48.000Z*
> Seraphina Therapeutics, based in San Diego, has recently gained scientific recognition for uncovering an emerging nutrit

### [Serina names Srini Tenjarla CTO; raises CEO Steve Ledger's salary](https://longbridge.com/en/news/283560686.md)
*2026-04-21T21:13:01.000Z*
> Serina has appointed Srini Tenjarla as Chief Technology Officer of its Serina (AL) subsidiary, effective April 20, 2026.

### [NYSE Accepts Serina Therapeutics Continued Listing Compliance Plan](https://longbridge.com/en/news/281737146.md)
*2026-04-06T07:00:50.000Z*
> Serina Therapeutics, Inc. has had its compliance plan accepted by NYSE American LLC, allowing until July 9, 2027, to mee

### [Pre-market hot trades in US stocks: Aprea Therapeutics pre-market down 9.53%; Serina Therapeutics pre-market up 7.22%](https://longbridge.com/en/news/281331893.md)
*2026-04-01T08:47:52.000Z*
> Aprea Therapeutics pre-market down 9.53%; Serina Therapeutics pre-market up 7.22%; Hub Cyber Security pre-market up 55.7